Strains and media
A. vinelandii strain DJ (wild-type strain; obtained from Dennis Dean, Virginia Tech, VA, USA)15 and nifL mutants (this study) were grown aerobically at 30°C in Burk's sucrose medium (B medium)47 or Burk's sucrose medium supplemented with 10 mM ammonium acetate (BN medium). Growth in B medium is referred to here as diazotrophic conditions and growth in BN medium is referred to here as non-diazotrophic conditions. Two-hundred-milliliter liquid cultures, contained in 500-ml baffled Erlenmeyer flasks, were incubated on a rotary shaker at 180 rpm. E. coli JM109 strain (Promega, Madison, WI) was used for cloning experiments. Ampicillin and kanamycin were used at 100 μg/ml and 50 μg/ml for E. coli, and 100 μg/ml and 5 μg/ml for A. vinelandii, respectively; rifampicin was used at 10 μg/ml for A. vinelandii.
Construction of the AvFM1 and AvFM4 strains
The AvFM1 and AvFM4 strains were obtained by gene disruption with an antibiotic resistance cassette KIXX between the two BglII sites, thereby removing the N-terminal domain (PAS1 and PAS2 domains) of the native NifL sequence. A DNA fragment containing the 1534 bp upstream and 1565 bp downstream genomic regions (Supplementary Fig. 2) of the nifL from the two BglII restriction sites was obtained by PCR, using genomic DNA from A. vinelandii strain DJ. Specific primers AvFM1-upstream-F-NdeI/AvFM1-upstream-R-EcoRI and AvFM1-downstream-F-EcoRI/AvFM1-downstream-R-HindIII (Supplementary Table 4) were used for the amplification of the 1534 bp upstream and 1565 bp downstream fragments, respectively. The PCR amplifications were performed using the Phusion High-Fidelity Taq Polymerase (Thermo Fisher, Waltham MA, USA) as described by the manufacturer. Amplification was performed using the following cycling parameters: an initial single step at 98°C for 30 s (denaturation) was followed by 35 cycles of the following: (a) 98°C for 10 sec (denaturation), (b) 64°C for 30 sec, and (c) 72°C for 2 min (elongation). A final single step at 72°C for 10 min followed these 35 cycles. The resulting fragments were cloned in pT7-7 ampicillin-resistant vector respectively48 (Supplementary Table 3) using NdeI/EcoRI and EcoRI/HindIII as restriction cloning sites to generate pFM1 plasmid. The KIXX cassette, containing the KanR gene and its aph promoter (paph::KIXX), was PCR amplified from pUC4-KIXX vector35 (Supplementary Table 2), with the following specific primers paph::KIXX-F-EcoRI and paph::KIXX-R-EcoRI (Supplementary Table 4) and using the Phusion High-Fidelity Taq Polymerase as described by the manufacturer (Thermo Fisher, Waltham MA, USA). The KIXX cassette was inserted in both orientations: in the same direction (pFM1-1) and opposite direction (pFM1-2) as nifLA transcription. The final constructs, pFM1-1 and pFM1-2 (Supplementary Table 2), were transformed into A. vinelandii strain DJ, as described previously49. KanR transformants (5 μg/ml kanamycin) were screened for resistance to ampicillin (AmpR; 100 μg/ml ampicillin); ampicillin-susceptible (AmpS) derivatives were assumed to have arisen from a double-crossover recombination event, such that the paph::KIXX-containing DNA replaced the wild-type nifL gene. The deletion of the N-terminal domain of the native NifL sequence was confirmed by PCR and sequencing.
Construction of the AvFM2 and AvFM5 strains
The AvFM2 and AvFM5 strains were obtained by gene disruption with an insertion of an antibiotic resistance cassette KIXX between the SalI and SmaI sites, thereby removing the C-terminal quarter of the native NifL sequence. A DNA fragment containing the 1276 bp upstream and 1306 bp downstream genomic regions of the nifL (Supplementary Fig. 2) bearing the SalI and SmaI restriction sites was obtained by PCR, using genomic DNA from A. vinelandii strain DJ. Specific primers AvFM2-upstream-F-NdeI and AvFM2-downstream-R-HindIII (Supplementary Table 3) were used to amplify a 2798 bp fragment. The PCR amplification was performed following the same procedure as previously mentioned. The resulting fragment was cloned in pT7-7 ampicillin-resistant vector48 (Supplementary Table 2) using NdeI and HindIII as restriction cloning sites to generate pFM2 plasmid. The KIXX cassette, containing the KanR gene and its aph promoter (paph::KIXX), was PCR amplified from pUC4-KIXX vector35 (Supplementary Table 2), with the following specific primers paph::KIXX-F-SmaI and paph::KIXX-R-SalI or paph::KIXX-F-SalI and paph::KIXX-R-SmaI (Supplementary Table 4) and using the Phusion High-Fidelity Taq Polymerase as described by the manufacturer (Thermo Fisher, Waltham MA, USA). The KIXX cassette was inserted into pFM2 plasmid (Supplementary Table 2) cut at restriction sites SalI and SmaI. The KIXX cassette was inserted in both orientations: in the same direction (pFM-2-1) and opposite orientation (pFM2-2) as nifLA transcription. The final constructs, pFM2-1 and pFM2-2 (Supplementary Table 2), were transformed into A. vinelandii strain DJ, as described previously49. KanR transformants were screened for double-crossover recombination events as previously described. The deletion of the C-terminal quarter of the native NifL sequence was confirmed by PCR and sequencing.
Construction of the AvFM3 strain
The AvFM3 strain was obtained by gene disruption with an antibiotic resistance cassette KIXX between the two BglII and SmaI sites, thereby removing the PAS domains, the Q linker, and the GHKL domain of the native NifL sequence. A DNA fragment containing the 1534 bp upstream and 1564 bp downstream genomic regions of the nifL from the BglII and SmaI restriction sites was obtained by PCR, using genomic DNA from A. vinelandii strain DJ. Specific primers AvFM1-upstream-F-NdeI/AvFM1-upstream-R-EcoRI and AvFM2-downstream-F-EcoRI/AvFM2-downstream-R-HindIII (Supplementary Table 3) were used for the amplification of the 1534 bp upstream and 1564 bp downstream fragments, respectively. The PCR amplifications were performed using the Phusion High-Fidelity Taq Polymerase (Thermo Fisher, Waltham MA, USA) as previously described. The resulting fragments were cloned in pT7-7 ampicillin-resistant vector respectively48 (Supplementary Table 2) using NdeI/EcoRI and EcoRI/HindIII as restriction cloning sites to generate pFM3 plasmid. The KIXX cassette, containing the KanR gene and its aph promoter (paph::KIXX), was PCR amplified from pUC4-KIXX vector35 (Supplementary Table 2), with the following specific primers paph::KIXX-F-EcoRI and paph::KIXX-R-EcoRI using the Phusion High-Fidelity Taq Polymerase as described by the manufacturer (Thermo Fisher, Waltham MA, USA). The KIXX cassette was inserted in both orientations: in the same direction (pFM3-1) and opposite orientation (pFM3-2) as nifLA transcription (Supplementary Table 2). The final constructs, pFM3-1 and pFM3-2 (Supplementary Table 2), were transformed into A. vinelandii strain DJ, as previously mentioned, following the procedure described by Page and von Tigerstrom49. KanR transformants were screened for double-crossover recombination events as previously described. The deletion of the PAS domains, the Q linker, and the GHKL domain of the native NifL sequence was confirmed by PCR and by sequencing.
Construction of the AvFM6 and AvFM7 strains
The constructs pFM1-2 and pFM2-2 (Supplementary Table 2) were transformed into A. vinelandii strain DJ10039 as previously mentioned following the procedure described by Page and von Tigerstrom49. KanR transformants were screened for double-crossover recombination events as previously described. The deletions of the PAS domains and the GHKL domain of the native NifL sequence were confirmed by PCR and by sequencing.
Construction of the AvFM8 and AvFM9 strains
Transformations of AvFM1 and AvFM2 competent cells were achieved by congression (coincidental transfer of genetic markers) with pFM1 and pDB303 plasmids or pFM2 and pDB303 plasmids, respectively (Supplementary Table 2), following the procedures described by Page and von Tigerstrom49. RifR transformants were selected on Burk medium containing rifampin (10 mg/ml) and subsequently screened for the loss of kanamycin resistance (KanR). Loss of kanamycin resistance indicated that the deletion of nifL within AvFM1 and AvFM2 strains was replaced by the DNA containing the pFM1 and pFM2 mutations through a double crossover event. The marker-less deletion of the N-terminal domain (AvFM8) and the C-terminal domain (AvFM9) of the native NifL sequence were confirmed by PCR and sequencing.
Construction of the AvFM10 and AvFM11 strains
The KIXX cassette, containing the open reading frame (ORF) of KanR gene was amplified by PCR from pUC4-KIXX vector35, using specific primers KIXX-F-EcoRI and KIXX-R-EcoRI or Kan-F-SmaI and Kan-R-SalI (Supplementary Table 3) and the Phusion High-Fidelity Taq Polymerase (Thermo Fisher, Waltham MA, USA). The open reading frame of the KanR gene was digested with EcoRI or SmaI and SalI and ligated to pFM1 and pFM2 plasmids respectively cut at restriction sites EcoRI or SalI and SmaI. The KIXX ORF was inserted in the opposite orientation as nifLA transcription. The resulting constructs pFM1-3 and pFM2-3 (Supplementary Table 2) were used with pDB303 vector in congression crosses with AvFM1 and AvFM2 strains, respectively, as previously described to generate AvFM10 and AvFM11 strains. The insertion/deletion of the N-terminal domain (AvFM10) and the C-terminal domain (AvFM11) of the native NifL sequence with the KIXX open reading frame sequence were confirmed by PCR and by sequencing.
Construction of the AvFM12 and AvFM15
The AvFM12 and AvFM15 strains were obtained by gene disruption using aph promoter34. The aph promoter region was isolated by PCR amplification from pUC4-KIXX vector35 (Supplementary Table 2), using specific primers paph-F-EcoRI and paph-R-EcoRI or paph-F-SmaI and paph-R-SalI (Supplemental Table 3). The fragment corresponding to the promoter region of aph was digested with EcoRI or SmaI and SalI and ligated to the pFM1, and pFM2 plasmids, respectively (Supplementary Table 2) cut at restriction sites EcoRI or SalI and SmaI. The promoter region of aph was inserted in the opposite orientation as nifLA transcription. The resulting constructs pFM1-4 and pFM2-4 (Supplementary Table 2) were used with pDB303 vector for congression crosses in AvFM1 and AvFM2 strains, respectively49. RifR transformants were selected on Burk medium containing rifampin (10 mg/ml) and subsequently screened for the loss of kanamycin resistance (KanR). The insertion/deletion of the N-terminal domain (AvFM12) and the C-terminal domain (AvFM13) of the native NifL sequence with aph were confirmed by PCR and by sequencing.
Construction of the AvFM13 and AvFM16 strains
The AvFM13 and AvFM16 strains were obtained by gene disruption using cydAB41 promoter sequence. The cydAB promoter region (pcydAB) was isolated by PCR amplification using genomic DNA from A. vinelandii strain DJ. The primers pcydAB-F-EcoRI and pcydAB-R-EcoRI, pcydAB-F-SmaI and pcydAB-R-SalI, were used for the amplification of 602 bp fragment (Supplementary Table 3). The fragment corresponding to the promoter region of cydAB was digested with EcoRI or SmaI and SalI and ligated to pFM1 plasmid and pFM2 plasmid respectively (Supplementary Table 2), cut at restriction sites EcoRI or SalI and SmaI. The promoter region of cydAB was inserted in the opposite orientation as nifLA transcription. The resulting constructs pFM1-5 and pFM2-5 (Supplementary Table 2) were used respectively with pDB303 vector for congression crosses in AvFM1 and AvFM2 strains49. RifR transformants were selected on Burk medium containing rifampin (10 mg/ml) and subsequently screened for the loss of kanamycin resistance (KanR). The insertion/deletion of the C-terminal quarter of the native NifL sequence with pcydAB (AvFM13, AvFM16) was confirmed by PCR and by sequencing.
Construction of the AvFM14 and AvFM17 strains
The AvFM14 and AvFM17 strains were obtained by gene disruption using cycB42 promoter sequence. The cycB promoter region (pcycB) was isolated by PCR amplification using genomic DNA from A. vinelandii strain DJ. The primers pcycB-F-EcoRI and pcycB-R-EcoRI, pcycB-F-SmaI and pcycB-R-SalI, were used for the amplification of 160 bp fragment (Supplementary Table 3). The fragment corresponding to the promoter region of cycB was digested with EcoRI or SmaI and SalI, and ligated to pFM1 plasmid and pFM2 plasmid respectively (Supplementary Table 2), cut at restriction sites EcoRI or SalI and SmaI. The promoter region of cycB was inserted in the opposite orientation as nifLA transcription. The resulting constructs pFM1-6 and pFM2-6 (Supplementary Table 2) were used respectively with pDB303 vector for congression crosses in AvFM1 and AvFM2 strains49. RifR transformants were selected on Burk medium containing rifampin (10 mg/ml) and subsequently screened for the loss of kanamycin resistance (KanR). The insertion/deletion of the C-terminal quarter of the native NifL sequence with pcycB (AvFM14, AvFM17) was confirmed by PCR and by sequencing.
Construction of the AvFM18, AvFM19, and AvFM20 strains
The aph promoter region was isolated by PCR amplification from pUC4-KIXX vector35, using specific primers paph-F and paph-R (Supplementary Table 3). The cydAB and cycB promoter regions were isolated by PCR amplification using genomic DNA from A. vinelandii strain DJ. The primers pcydAB-F and pcydAB-R, pcycB-F and pcycB-R, were used to amplify 602 bp and 160 bp fragments, respectively (Supplementary Fig. 2). The lacz gene was isolated by PCR amplification from pDB133543 using specific primers lacZ-F and lacZ-R (Supplementary Table 3). The paph::lacZ, pcydAB::lacZ, pcycB::lacZ fragments were generated by SOE PCR using the Phusion High-Fidelity Taq Polymerase (Thermo Fisher, Waltham MA, USA) as described by the manufacturer. The list of specific primers used for SOE PCRs is listed in the Supplementary Table 3. The paph::lacZ, pcydAB::lacZ, pcycB::lacZ fragments were cloned in pDB1332 (Supplementary Table 2) using EcoRV restriction site. A. vinelandii strain DJ was transformed with pDB133550 (Supplementary Table 2) as previously described49. strain transformed with pDB1335 plasmid harboring scrX gene interrupted with lacZ and kanamycin antibiotic resistance cartridges (DJ1418) (Supplementary Table 2) was selected by plating onto Burks agar plates supplemented with X-Gal and kanamycin. The final constructs pFM4, pFM5, and pFM6 (Supplementary Table 2) were used respectively with pDB303 vector for congression crosses in A. vinelandii strain DJ1418. The transformation procedures employed were those described by Page and von Tigerstrom49. RifR transformants were selected on Burk medium containing rifampin (10 mg/ml) and X-Gal (60mg/ml); white colonies are subsequently screened for the loss of kanamycin resistance (KanR). Loss of kanamycin resistance indicated that the deletion of scrX::lacZ-Kan was replaced by the paph::lacZ, pcydAB::lacZ, or pcycB::lacZ DNA containing the mutation through a double crossover event.
Construction of the AvFM21 and AvFM22 strains
The constructs pFM1-2 and pFM2-2 (previously described) (Supplementary Table 2) were transformed into A. vinelandii Δrnf1 strain40, as described previously49. KanR transformants were screened for double-crossover recombination events as previously described. The deletion of the N-terminal and C-terminal domains of the native NifL sequence were confirmed by PCR and sequencing.
Ammonia quantification
Samples of cultures were taken at different times and centrifuged (14,000 × g for 5 min). The cell pellets were used for protein quantification, and the filtered supernatants (through cellulose acetate membranes; pore size, 0.25 mm) were used for ammonia quantification. Appropriate amounts of filtered supernatant (filtration through cellulose acetate membranes; pore size, 0.25 mm) were tested for the presence of ammonia by the indophenol method50. This consisted of the addition, in order, of 0.5 ml of phenol-sodium nitroprusside solution (phenol, 50 g/L; sodium nitroprusside, 0.25 g/L), 0.5 ml of sodium hypochlorite solution (0.1 M), and 0.1 ml of sample. The mixture was incubated for 30 min at room temperature. The absorbance at 625 nm was measured, and the ammonia concentration was estimated from a standard curve obtained with ammonia chloride solutions at various concentrations assayed with the same reagent solutions.
Protein quantification
Harvested cell pellets were disrupted by one cycle of sonication (7 W, 50 s; ultrasonic homogenizer, model 3000; Biologics, Inc., Cary, NC, USA). Protein assays were performed on the same cell lysate for each time point and tested condition. Protein was quantified using the Coomassie protein assay from Thermo Scientific (Waltham, MA, USA). Thirty microliters of sample were mixed with 1.5 ml of Thermo Scientific reagent and incubated at room temperature for 10 min. The absorbance at 595 nm was measured using a spectrophotometer (Thermo Spectronic BioMate 3; Thermo Scientific). The protein content of the sample was calculated using a standard curve (albumin standard used as described by the manufacturer).
Galactosidase assay
ß-Galactosidase activity was determined using an assay adapted from a method described previously by Miller51. Cells were grown in sucrose-containing medium to mid-log or late log phase, and assays were conducted using the soluble fraction of crude extracts prepared by sonication and centrifugation. Relative ß-galactosidase activities represent the specific rate of the absorbance change at 414 nm for the experimental samples divided by the control sample.
RNA extraction
Total RNA was isolated from A. vinelandii cells using the RNeasy Minikit (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions. Genomic DNA was removed from RNA samples by DNase treatment (RNase-free DNase I; Ambion, Grand Island, NY, USA) for 30 min at 37°C. The Qiagen RNeasy MinElute kit (Qiagen) was used to purify DNase-treated total RNA from degraded DNA, DNase, contaminating proteins, and potential inhibitors of the reverse transcriptase reaction. The concentration of the eluted RNA was determined with a NanoDrop analyzer.
Reverse transcription reactions
First-strand cDNA synthesis was primed from the purified total RNA template using (dT)12-18 primers. The reverse transcription reaction was performed using the reverse transcriptase SuperScript III kit (Invitrogen, Grand Island, NY, USA), as described by the manufacturer. (dT)12-18 primers were annealed to 250 ng of total RNA and extended for 1 h at 50°C using 200 units of SuperScript III reverse transcriptase.
Real-time RT-PCR
Steady-state levels for specific mRNA transcripts from each sample were quantified by absolute real-time RT-PCR using the engine Rotor-Gene Q system (Qiagen). One microliter of single-stranded cDNA from the reverse transcriptase reaction mixture (see above) was used as the template for the real-time PCR experiments. The real-time PCR amplifications were performed using reagents from the DyNAmo SYBR green real-time PCR kit (Finnzymes, Lafayette, CO, USA). Specific primers were designed to amplify gene regions consisting of 90 to 110 nucleotides. The primers used for real-time PCR (nifA-F, nifA- R, nifH-F, nifH-R, rnfA1-F, rnfA1-R, rnfD1-F, rnfD1-R, gyrB-F, gyrB-R) (Supplementary Table 3) are described in and were designed using the Primer3 software. Amplification by RT-PCR of single products of the expected sizes was verified on 2% (wt/vol) agarose gels, and the specificity of PCR products was confirmed by sequencing. Melting curve analyses were performed on all PCR products to ensure that single DNA species were amplified. Real-time PCR amplifications were performed using the following cycling parameters: an initial single step at 95°C for 10 min (denaturation) was followed by 40 cycles of the following: 94°C for 10 s (denaturation), 70°C for 20 s (primer annealing), and 72°C for 30 s (elongation). A final single step at 72°C for 1 min followed these 40 cycles. The relative expression ratio of a target gene was calculated based on the 2−ΔΔCT method52, using the average cycle threshold (CT ) calculated from triplicate measurements. Relative expression ratios from three independent experiments are reported. gyrB (Avin_00040) was used as a constitutive control gene for normalization. Relative abundances for each tested culture conditions were then standardized to the BN medium control condition.
Sterilization and germination of rice seeds
For all plant experiment, the outer coat of rice seeds was removed prior surface sterilization in 2% bleach for 15 min. Rice seeds were washed five times with sterile deionized water and then imbibed overnight at room temperature. Post imbibition, the rice seeds were spread on a sterile wet AnchorTM 38# Regular Weight Seed Germination Paper in Petri dishes and incubated at room temperature for three days. Germinated rice seeds were then transferred into germination pouches and kept in growth chambers for a week under 16 hours of light and 8 hours of dark at 22°C. Milli-Q water was added to the germination pouches buckets to keep some moisture to avoid drying of the seedlings.
Coculture of rice seedlings and A. vinelandii strains
After one week in growth chambers, rice seedlings were inoculated with bacterial strains (wild-type, DJ100, AvFM2, AvFM16, AvFM17) grown in Burks medium, at 180 rpm and 30°C for 48 h and adjusted to OD 1.0 using fresh B medium. Pouches containing inoculated rice seedlings were then transferred in sealed Supelco Push-pull gas bags and 2% of 15N2 or 14N2 gas were added to each bag. Each bag was placed into growth chambers for one week at 22°C (16 h light and 8 h dark).
Sampling for isotope ratio mass spectrometry
After a week of coculture, the shoots were harvested and dried at 65°C for three days. Dried shoots were powdered using metal balls and a bead beater (Mixer Mill MM 400, Retsch). The powdered samples were weighed prior their submission to the mass spectrometry facility of the Department of Soil Science at the University of Wisconsin - Madison.